Bristol, UK
08043694079
+919673008130
Anti Cancer

Bortlieva 3.5mg Injection Wholesale Price | Buy Bulk Bortezomib India to USA, UK, Australia, Saudi Arabia, UAE — PRIMECARE IMPEX

In stockcod not available
Phone Number

08043694079

Please keep 0 before dialling the number.

Mon-Thu: 10 AM - 2 PM • Fri: 3 PM - 7AM

Address Bristol , Bristol City , England

Bristol, UK, United Kingdom, 1

Description

Extensive Product Profile: Understanding Bortlieva 3.5mg Injection Bortlieva 3.5mg Injection contains Bortezomib, an advanced, targeted antineoplastic agent belonging to the class of proteasome inhibitors. Manufactured under stringent international quality controls by Allieva Pharma Private Limited, it is globally utilized by hematologists and oncologists as a foundational component in treating complex hematological malignancies. 1. Clinical Indications & Usage Multiple Myeloma (Previously Treated): Used as monotherapy or in combination with other anti-cancer agents (such as pegylated liposomal doxorubicin or dexamethasone) for adult patients who have relapsed after or failed to respond to at least one prior therapy, or for whom stem cell transplantation is ineligible. Newly Diagnosed Multiple Myeloma: Integrated alongside alkylating agents and corticosteroids (e.g., melphalan and prednisone) as a first-line therapy for patients who are not candidates for high-dose chemotherapy and bone marrow transplantation. Pre-Transplant Induction Therapy: Prescribed in combination regimens (such as with dexamethasone, thalidomide, or cyclophosphamide) to safely reduce tumor burden before high-dose chemotherapy and autologous stem cell rescue. 2. Mechanism of Action: How Bortlieva Works Reversible 26S Proteasome Inhibition: It selectively binds to and blocks the chymotrypsin-like activity of the 26S proteasome—the primary cellular enzyme complex responsible for breaking down damaged or misfolded proteins. Disruption of Homeostasis: By preventing targeted protein degradation, it causes an acute, toxic buildup of faulty intracellular proteins. This triggers an overwhelming endoplasmic reticulum stress response. 3. Administration and Dosing Guide Administration Route: Bortlieva 3.5mg must be administered exclusively by a registered oncology healthcare professional in a clinical or hospital setting. Self-administration is strictly prohibited. Modes of Delivery: It can be delivered either via Subcutaneous (SC) injection (under the skin, typically into the thigh or abdomen at a concentration of 2.5 mg/mL) or Intravenous (IV) injection (directly into a vein as a 3 to 5-second bolus at a concentration of 1 mg/mL). The SC route is often preferred to reduce the risk of peripheral nerve toxicities. ⚠️ Safety, Side Effects, and Monitoring Peripheral Neuropathy: May induce new or worsening nerve damage, presenting as tingling, burning sensations, numbness, or pain in the hands and feet. Hematological Toxicities: Frequent cycles can induce transient thrombocytopenia (low platelet count), neutropenia (low white cells), and anemia. Complete Blood Counts (CBC) must be checked before every single dose. Hypotension: Orthostatic/postural hypotension can occur. Caution must be exercised in patients with pre-existing dehydration or those taking anti-hypertensive medications. Common Side Effects: Nausea, vomiting, diarrhea, constipation, profound fatigue, pyrexia (fever), reduced appetite (anorexia), headache, and sleep disturbances. 📦 Storage and Handling Specifications Temperature Range: Store the unconstitutioned lyophilized powder vial below 30°C (86°F) in a dry, temperature-controlled facility. (Note: Certain institutional guidelines recommend refrigeration at 2°C to 8°C; check specific batch criteria upon receipt). Light Sensitivity: Keep the vial enclosed inside its original manufacturer box to shield the active chemical compound from direct light and UV exposure. 📄 Regulatory and Compliance Documentation Authentic Manufacturer Certificate of Analysis (COA) Verified Batch-Specific Ledger and Origin Documentation Global Drug Import-Export Compliance PRESCRIPTION MEDICINE IS: YES Clinical Disclaimer: This profile is compiled exclusively for international wholesale procurement, institutional buyers, and commercial distribution research. Bortlieva 3.5mg Injection is a specialized cytotoxic agent available exclusively under strict oncology authorization. It must be dispensed and administered solely under the direct guidance of a registered oncology specialist. Why Choose Primecare Impex? 100% Traceability Cross-Border Regulatory Support Secure Cold-Chain & Bulk Capacity 📞 Contact PRIMECARE IMPEX — Bulk Pharmaceutical Exporter from India [A Group of Prime Care Impex Pvt. Ltd.] Your trusted logistics partner and bulk pharmaceutical supplier. 🌐 Corporate Website: www.medicineexporterfromindia.com 📧 Commercial Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Global Distributor 📲 Direct WhatsApp Line: +91 9673008130 🔗 Instant Chat Access: https://wa.me/919673008130

Keywords

Other Products

view all

6814772a5d263414004dd4a4 Card 2

product image
Anti Cancer

Learn about Doxorubicin Injection 20 mg / 50 mg, including clinical uses, mechanism of action, administration guidance, safety monitoring, storage, and regulatory documentation information. Doxorubicin Hydrochloride Injection 20 mg / 50 mg – Anthracycline Chemotherapy Information Guide Doxorubicin HCl Injection Doxorubicin Hydrochloride Injection is an anticancer medicine used in oncology care under the supervision of experienced healthcare professionals. It belongs to the anthracycline class of chemotherapy medicines and is commonly used as part of cancer treatment protocols recommended by oncologists. Doxorubicin Injection may be available in different strengths such as 20 mg and 50 mg, depending on the approved manufacturer, country registration, and clinical requirement. This page is created for educational and product-information purposes only and does not replace medical advice, diagnosis, or treatment. Doxorubicin should be used only in hospitals, oncology centers, or clinical settings where proper monitoring, emergency support, and trained medical staff are available. Doxorubicin Injection Information by Location Washington, USA – Doxorubicin Injection Information Patients and healthcare information seekers in Washington may search for Doxorubicin Injection to understand its role in oncology treatment, safety profile, storage requirements, and clinical administration. Doxorubicin is not a self-administered medicine and should only be used under an oncologist’s direction. London, UK – Doxorubicin Injection Information In London and across the UK, Doxorubicin Injection is generally associated with specialist cancer care. Patients should follow NHS, private oncology clinic, or licensed healthcare provider guidance for treatment planning, monitoring, and medicine access. Riyadh, Saudi Arabia – Doxorubicin Injection Information In Riyadh, Doxorubicin Injection may be used in oncology settings where cancer medicines are handled by qualified medical teams. Proper documentation, prescription validation, and local regulatory compliance are important for oncology medicines. Canberra, Australia – Doxorubicin Injection Information In Canberra and Australia, Doxorubicin Injection is a prescription oncology medicine used only under medical supervision. Patients should consult a registered oncologist or hospital pharmacy for treatment-related guidance. UAE – Doxorubicin Injection Information In the UAE, Doxorubicin Injection information is usually relevant to oncology hospitals, cancer treatment centers, and licensed healthcare professionals. This medicine requires careful handling, prescription control, and patient monitoring. Kingston, Jamaica – Doxorubicin Injection Information In Kingston, Jamaica, Doxorubicin Injection may be discussed in relation to cancer treatment protocols, chemotherapy safety, and oncology medicine availability. Patients should always consult qualified cancer-care professionals. How Doxorubicin Works Doxorubicin works by interfering with the growth and division of cancer cells. It is an anthracycline chemotherapy medicine that affects DNA function inside rapidly dividing cells. Its action may include: Interference with DNA replication Inhibition of topoisomerase II activity Damage to cancer-cell DNA structure Reduction of cancer-cell multiplication Induction of cancer-cell death through chemotherapy action Because doxorubicin can also affect healthy rapidly dividing cells, careful monitoring is required during treatment. Why Choose Primecare Impex Primecare Impex provides product-information support for pharmaceutical and oncology products exported from India. The company focuses on documentation, product identification, packaging details, and healthcare-oriented communication. Primecare Impex supports: Oncology product information Export documentation assistance Product availability clarification Manufacturer and batch-detail coordination Temperature-sensitive handling guidance where applicable Communication support for healthcare-related inquiries Primecare Impex does not recommend self-medication. Oncology medicines should be used only under prescription and specialist medical supervision. Contact Primecare Impex — Pharmaceutical Exporter from India Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Business Type: Exporter | Supplier | Distributor WhatsApp: +91 9673008130 WhatsApp Link: https://wa.me/919673008130 For prescription oncology products, buyers should ensure compliance with local laws, prescription requirements, import documentation, and healthcare regulations. What is Doxorubicin Injection? Doxorubicin Injection is an anthracycline chemotherapy medicine used in specialist oncology treatment. 2. Is Doxorubicin Injection used for cancer treatment? Yes, it may be used in selected cancer treatment protocols under an oncologist’s supervision.

6814772a5d263414004dd4a4 Card 2

product image
Anti Cancer

Learn about DOXIL Injection 20 mg, containing Doxorubicin HCl Liposome Injection 20 mg/10 ml, including product profile, clinical use, mechanism, administration, safety monitoring, storage, and regulatory information from Primecare Impex. DOXIL Injection 20 mg – Doxorubicin HCl Liposome Injection 20 mg/10 ml for Oncology Care DOXIL Injection 20 mg DOXIL Injection 20 mg contains Doxorubicin Hydrochloride Liposome Injection 20 mg/10 ml, equivalent to 2 mg/ml. It is a liposomal formulation of doxorubicin, an anthracycline chemotherapy medicine used in oncology treatment under the supervision of a qualified cancer specialist. The liposomal form is designed to carry doxorubicin inside tiny lipid-based vesicles. This formulation helps alter how the medicine circulates in the body compared with conventional doxorubicin. Because it is a chemotherapy medicine, DOXIL Injection should be administered only in a hospital, cancer center, or supervised clinical setting. DOXIL Injection 20 mg is generally used as part of a carefully planned cancer treatment protocol. The exact treatment schedule depends on the patient’s diagnosis, previous therapy, body surface area, cardiac condition, blood counts, liver function, and the oncologist’s clinical decision. DOXIL Injection 20 mg Information for Washington, London UK, Riyadh Saudi Arabia, Canberra Australia, UAE, and Kingston Jamaica Primecare Impex provides informational support for healthcare-related inquiries connected with oncology products such as DOXIL Injection 20 mg. Requirements for prescription medicines, import permission, patient documentation, cold-chain handling, and customs clearance may vary by region. Target information areas: Washington, USA DOXIL Injection 20 mg information for oncology hospitals, cancer-care procurement teams, and medical professionals looking for Doxorubicin HCl Liposome Injection details. London, UK Doxorubicin Liposomal Injection 20 mg/10 ml information for regulated oncology supply chains, cancer treatment centers, and healthcare institutions. Riyadh, Saudi Arabia DOXIL Injection 20 mg product information for oncology departments, hospital procurement teams, and healthcare professionals requiring regulated chemotherapy product documentation. Canberra, Australia Doxorubicin HCl Liposome Injection 20 mg/10 ml information for cancer-care settings, clinical pharmacy teams, and oncology-focused healthcare organizations. UAE DOXIL Injection 20 mg information for oncology product inquiry, hospital pharmacy review, regulatory documentation, and controlled medical supply requirements. Kingston, Jamaica Doxorubicin Liposomal Injection 20 mg information for cancer-care product research, oncology treatment support, and medical import documentation review. How DOXIL Injection Works DOXIL contains doxorubicin in a liposomal delivery system. Doxorubicin belongs to the anthracycline class of chemotherapy medicines. Its anticancer action is mainly related to: Step 1: Doctor Evaluation The oncologist reviews the patient’s diagnosis, treatment history, cardiac status, blood reports, liver function, and previous chemotherapy exposure. Step 2: Dose Calculation The dose is usually calculated by the doctor based on body surface area, cancer type, treatment protocol, and patient condition. Step 3: Pre-Treatment Monitoring Before administration, healthcare professionals may check CBC, liver function, kidney function, cardiac function, infection status, and overall performance condition. Step 4: Infusion Preparation The injection must be prepared according to approved handling procedures for cytotoxic medicines. It should not be mixed or handled casually. Step 5: Intravenous Infusion The medicine is administered slowly through IV infusion. Infusion speed and observation requirements depend on the clinical protocol. Step 6: Patient Observation During and after infusion, the patient is monitored for infusion reactions, allergic symptoms, vital signs, and treatment tolerance. Why Choose Primecare Impex Primecare Impex focuses on pharmaceutical product information, sourcing support, and export documentation assistance for regulated healthcare products. Key Strengths Oncology Product Knowledge Primecare Impex works with specialty medicines and understands the importance of correct product details, composition, storage, documentation, and professional handling. Global Inquiry Support Primecare Impex supports product inquiries from multiple international regions including the USA, UK, Saudi Arabia, Australia, UAE, and Jamaica. Contact Primecare Impex — Pharmaceutical Exporter from India Company: Primecare Impex Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Business Type: Exporter | Supplier | Distributor WhatsApp: +91 9673008130 WhatsApp Link: https://wa.me/919673008130

6814772a5d263414004dd4a4 Card 2

product image
Anti Cancer

Learn about Docetere Injection 20 mg/0.5 ml, containing Docetaxel 20 mg, an anticancer chemotherapy medicine used under medical supervision. Read product profile, indications, mechanism, administration, safety, storage, documentation, and country-wise information for Washington, London, Riyadh, Canberra, UAE, and Kingston Jamaica. Docetere Injection 20 mg/0.5 ml – Docetaxel 20 mg Chemotherapy Injection for Oncology Care Docetere Injection 20 mg Product Name: Docetere Injection 20 mg/0.5 ml Generic Name: Docetaxel Strength: 20 mg Dosage Form: Injection / Concentrate for IV Infusion Packing Size: 1 Vial Therapeutic Category: Anticancer Medicine / Chemotherapy Medicine Use: Used in oncology treatment under the guidance of a qualified cancer specialist Administration Route: Intravenous infusion only Prescription Status: Prescription-only oncology medicine Docetere Injection 20 mg contains Docetaxel, a chemotherapy medicine used in cancer treatment protocols. It belongs to a group of anticancer medicines known as taxanes. Docetaxel works by interfering with cancer cell division and is used only under the supervision of trained healthcare professionals. This medicine is not suitable for self-use. It must be prepared, diluted, administered, monitored, and disposed of according to hospital oncology protocols. Step 1: What Is Docetere Injection 20 mg? Docetere Injection 20 mg is an injectable chemotherapy medicine containing Docetaxel 20 mg. It is supplied in a single vial and is used as part of cancer treatment plans prescribed by oncologists. Docetaxel may be used alone or in combination with other anticancer medicines depending on the type of cancer, stage of disease, previous treatment history, body surface area, blood count, liver function, and overall patient condition. Step 2: Clinical Indications & Usage Docetaxel is used in oncology care for selected cancer types. Depending on the approved label, hospital protocol, and doctor’s decision, it may be considered in treatment plans for: Breast Cancer Docetaxel may be used in locally advanced or metastatic breast cancer and in some adjuvant treatment combinations. Non-Small Cell Lung Cancer It may be used in certain patients with locally advanced or metastatic non-small cell lung cancer. Prostate Cancer Docetaxel is used in selected prostate cancer treatment protocols, often with other supportive medicines as directed by the oncologist. Gastric Cancer It may be included in specific chemotherapy combinations for advanced gastric cancer. Head and Neck Cancer Docetaxel may be used in certain head and neck cancer protocols as part of combination therapy. Important: The exact use depends on the doctor’s prescription, local regulatory approval, cancer type, treatment line, and patient health status. Step 3: Mechanism of Action – How Docetere Injection Works Docetere Injection contains Docetaxel, which is a taxane chemotherapy agent. Cancer cells grow and divide rapidly. Docetaxel works by disturbing the internal structure needed for cell division. In simple words: Cancer cells need microtubules to divide. Docetaxel affects microtubule function. This prevents cancer cells from dividing normally. As a result, cancer cell growth may slow down or stop. The damaged cancer cells may then die. This action makes Docetaxel useful in chemotherapy treatment plans. However, because chemotherapy can also affect some normal fast-growing cells, side effects may occur and regular monitoring is necessary. Step 4: Administration and Dosing Guide Docetere Injection 20 mg should be administered only by trained healthcare professionals in a hospital, cancer center, or oncology day-care unit. General Administration Points Route: Intravenous infusion only Use: Under oncologist supervision Preparation: Dilution and preparation must follow product label and hospital protocol Dose: Usually calculated based on body surface area and clinical condition Why Choose Primecare Impex Primecare Impex provides pharmaceutical product information and export support for healthcare-related requirements from India. The focus is on genuine product communication, proper documentation, clear product details, and professional support. Primecare Impex Highlights Pharmaceutical exporter from India Product information support Oncology medicine category experience Documentation support where applicable Clear communication for international enquiries Support for product profile, packing, strength, and availability details Professional handling of medicine-related enquiries 📞 Contact Primecare Impex — Pharmaceutical Exporter from India For product profile details, availability information, documentation support, and enquiry assistance: Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Business Type: Exporter | Supplier | Distributor WhatsApp: +91 9673008130 WhatsApp Link: https://wa.me/919673008130